Dr. Miraz Rahman

Biography

Miraz Rahman is a Professor of Medicinal Chemistry at King’s College London, where he leads research in synthetic medicinal chemistry, focusing on drug discovery and development. His academic journey includes completing a PhD at UCL School of Pharmacy and extensive industry experience prior to returning to academia. His research combines computational chemistry and chemical biology with a particular emphasis on anticancer and anti-infective agents. Noteworthy is his work on developing PROTACs targeting transcription factors and innovative drug-like payloads for antibody–drug conjugates. Professor Rahman has a strong collaboration network, engaging with both academic and clinical partners to facilitate the translation of new therapeutic candidates. He has published over 120 research papers and holds 24 patents, notably in the development of pyrrolobenzodiazepine (PBD) DNA-binding agents. He is also active in antimicrobial drug discovery, focusing on creating next-generation antibiotics to tackle the issue of resistance. In addition to his research achievements, he co-founded several biotech companies, enhancing his influence on translational medicinal chemistry, and has been recognized for his entrepreneurial spirit, culminating in the formation of Kings' spin-out Aethox Therapeutics and other ventures.

Research Interests

Experience